Bangolah  I.E. Affeam, Shellaleh  L.N. Alloula, Accomodo  O.Q. Semeyannah, 
    Norstictic Acid Inhibits the Growth of Murine SV40 Transformed Lymphoid Carcinoma 
  Cells <I>In vitro</I>,
    Research Journal of Pharmacology,
    Volume 7,Issue 3,
    2013,
    Pages 26-28,
    ISSN 1815-9362,
    rjpharm.2013.26.28,
    (https://makhillpublications.co/view-article.php?doi=rjpharm.2013.26.28)
    Abstract: Researchers test the effects of Norstictic acid, secondary 
  metabolite of the lichen <I>Buellia zahlbruckneri</I>, on the growth of murine 
  SV40 transformed lymphoid carcinoma cells <I>in vitro</I>. Researchers find 
  that Norstictic acid is a potent inhibitor of growth. Researchers, also find 
  that Norstictic acid increases sensitivity of cells to radiation and this effect 
  is significant at a radiation intensity lower than the standard intensity of 
  cancer radiotherapy. On the basis of this study, Norstictic acid shows promise 
  for combined-modality cancer treatment.
    Keywords: Norstictic acid;cancer;growth;radiotherapy;in vitro;Buellia zahlbruckneri